Last reviewed · How we verify
NCT06107439: LIPOKINES
Impact of Lipodystrophy on the Inflammatory State of Non-diabetic Dunnigan Reunion Island Subjects
NA trial testing Bood and urine sampling in Lipodystrophy in 80 participants. Status unknown.
13 August 2024
Quick facts
| Lead sponsor | Centre Hospitalier Universitaire de la Réunion |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | health services research |
| Enrollment | 80 |
| Start date | 14 August 2023 |
| Primary completion | 13 August 2024 |
| Estimated completion | 13 August 2025 |
| Sites | 1 location across Reunion |
Drugs / interventions tested
- Bood and urine sampling — full drug profile →
Conditions studied
- Lipodystrophy — all drugs for Lipodystrophy →
- Dunnigan Syndrome — all drugs for Dunnigan Syndrome →
Sponsor
Centre Hospitalier Universitaire de la Réunion
Who can join
18 and older, any sex, with Lipodystrophy or Dunnigan Syndrome. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Few data and small numbers affect the inflammatory profile of Dunnigan patients. The levels of certain pro-inflammatory biomarkers would be found higher in these subjects compared to control individuals. However, in these studies, several confounding factors were not taken into account such as smoking, an underlying chronic inflammatory disease such as diabetes and could limit the interpretation of the results. There is no other observation of the anti-inflammatory status of these patients.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06107439
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Lipodystrophy
Currently open trials in the same condition.
- NCT05996536 — Feasibility of Adipose Tissue Triglyceride (TG) Labelling in Familial Partial Lipodystrophy (FPLD) · recruiting
- NCT06236932 — Susceptibility to Infectious Diseases in obEsity: an endocRine trAnslational socioLogic Evaluation, "SIDERALE" · NA · recruiting
- NCT05789251 — Assess the Possibility of Diagnosing Diabetes and Rediabetes Following Oral Induced Hyperglycemia in Patients With Dunni · NA · recruiting
- NCT05419037 — Natural History of Pregnancy and Pregnancy Outcomes in Metreleptin-Treated vs Untreated Subjects With Lipodystrophy · recruiting
- NCT02262806 — Compassionate Use of Metreleptin in Previously Treated People With Partial Lipodystrophy · Phase 2 · active not recruiting
Other Centre Hospitalier Universitaire de la Réunion trials
Trials by the same sponsor.
- NCT06697262 — Impact of a Telemonitoring Device on the Occurever at Home in Children at Risk of Chemotherapy-Induced Neutropenia · NA · not yet recruiting
- NCT07444515 — Prospective AnalysiS of Self medIcation With phytOtherapy in Nephropatic Patients. · NA · not yet recruiting
- NCT07190560 — Against Chikungunya Virus and Neonatal Infection · NA · not yet recruiting
- NCT07365670 — Comparison of the Best Method for Measuring Anti-Xa Activity in Children Receiving Unfractionated Heparin in Cardiac Int · NA · not yet recruiting
- NCT06485310 — Interest of a TEteleconsultation of a Psychological Support Nurse on Psychological Distress in Patients With a Primary M · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06107439 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Centre Hospitalier Universitaire de la Réunion
- Last refreshed: 30 October 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06107439.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing